From the comfort of your home
Clinically proven RLRL therapy that controls myopia progression with up to 87.7% efficacy.
Repeated Low-Level Red-Light therapy stimulates blood flow in the ocular fundus, thickening the choroidal layer to control axial elongation and myopia progression.
Just 3 minutes per session, twice daily, 5 days a week. Simple touchscreen control makes it suitable for children as young as 3 years old.
Prescribed by eye care professionals for safe home use. No need for medication, eye drops, or contact lenses, perfect for non-compliant children.
Approved in over 30 countries with rigorous safety testing. Complies with Australian Standard IEC 60825-1:2014 for laser products safety.
Everything you need to know about EyeRising RLRL therapy
Need more information?
Visit the official EyeRising website for complete details
Visit EyeRising InternationalDiscover the clinically proven EyeRising device and learn how RLRL therapy can help manage your child's myopia progression.
